For example, in breast cancer, patients who responded better to neoadjuvant chemotherapy had significantly higher levels of HLA-DR expression among CD8+ T cells that had infiltrated the tumour, compared to non-responders (Saraiva et al., 2018). This evidence concerns the gene CD8A and breast carcinoma.